A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

336

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions

HypertensionDiabetes

Interventions

DRUG

aliskiren

Trial Locations (7)

Investigative Site, Salisbury

Investigative Site, Kortrijk

Investigative Site, Bucharest

Investigative Site, Madrid

Investigative Site, Stockholm

Novartis Pharmaceuticals, Basel

Investigative Site, Kiev